Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Psyence Group Inc (PSYG.CN)

Psyence Group Inc (PSYG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,100
  • Shares Outstanding, K 140,031
  • Annual Sales, $ 0 K
  • Annual Income, $ -69,445 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 3.15
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.49
  • Most Recent Earnings $0.01 on 08/29/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0100 +50.00%
on 11/12/24
0.0200 -25.00%
on 10/15/24
unch (unch)
since 10/11/24
3-Month
0.0100 +50.00%
on 11/12/24
0.0350 -57.14%
on 08/30/24
-0.0100 (-40.00%)
since 08/09/24
52-Week
0.0100 +50.00%
on 11/12/24
0.1200 -87.50%
on 11/15/23
-0.0350 (-70.00%)
since 11/10/23

Most Recent Stories

More News
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE FOR PALLIATIVE CARE

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament"), a clinical-stage natural psychedelic drug development company, and Psyence...

FLHLF : 0.0429 (+8.61%)
PSYG.CN : 0.0150 (unch)
PSYGF : 0.0119 (-45.91%)
The Power Play by The Market Herald Releases New Interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and Empower Clinics

VANCOUVER, BC / ACCESSWIRE / June 2, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Avrupa Minerals, good natured Products, Hank Payments, Psyence Group, and...

AVU.VN : 0.035 (+16.67%)
GDNP.VN : 0.015 (unch)
HANK.VN : 0.050 (+11.11%)
PSYG.CN : 0.0150 (unch)
CBDT.CN : 0.050 (unch)
Psyence Group Corporate Update

Highlights: Partnership with CRO Clerkenwell Health to design and deliver Psyence’s UK clinical trial progressing; exclusive licensing agreement with...

PSYG.CN : 0.0150 (unch)
PSYGF : 0.0119 (-45.91%)
Psyence Taps Another Pharma Exec to Drive its Clinical Program

TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (unch)
PSYGF : 0.0119 (-45.91%)
Market Movers. Today’s Top Stock Picks For New & Trending Opportunities

Market Movers. Today's Top Stock Picks For New & Trending Opportunities

BAU.VN : 0.060 (+9.09%)
BAUFF : 0.0349 (-2.51%)
LIT.VN : 0.145 (-3.33%)
PNXLF : 0.2415 (-6.90%)
VEJI.CN : 0.0050 (-50.00%)
VEJIF : 0.0200 (-61.90%)
EWG.CN : 0.1700 (unch)
EWGFF : 0.0001 (-99.67%)
NFTX.NE : 0.3350 (-1.47%)
CRDL.TO : 2.67 (-2.20%)
CRDL : 1.9100 (-2.55%)
AALI.VN : 0.025 (unch)
The Power Play by The Market Herald Releases Interviews With Hank Payments, Red Pine Exploration, Affinor Growers, Nextech AR, Star Navigation, and Psyence

VANCOUVER, BC / ACCESSWIRE / April 19, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Hank Payments, Red Pine Exploration, Affinor Growers, Nextech AR, Star...

FH.NE : 0.0300 (-14.29%)
HANK.VN : 0.050 (+11.11%)
RPX.VN : 0.125 (+4.17%)
AFI.CN : 0.0500 (unch)
NTAR.CN : 0.0500 (-9.09%)
NEXCF : 0.0370 (-9.31%)
SNA.CN : 0.0050 (unch)
PSYG.CN : 0.0150 (unch)
FH : 1.52 (+9.35%)
Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products

The partnership leverages Psyence’s expertise in fungi cultivation and palliative care as well as Filament’s expertise in the manufacture of pharmaceutical...

PSYG.CN : 0.0150 (unch)
PSYGF : 0.0119 (-45.91%)
FILAMENT HEALTH AND PSYENCE ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR NATURAL PSILOCYBIN PRODUCTS

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0429 (+8.61%)
PSYG.CN : 0.0150 (unch)
PSYGF : 0.0119 (-45.91%)
Psyence Group Announces DTC Eligibility Approval in the U.S.

TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.0150 (unch)
The Power Play by The Market Herald Releases Interviews With Opawica Explorations, Psyence Group, and C3 Metals

VANCOUVER, BC / ACCESSWIRE / February 7, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Opawica Explorations, Psyence Group, and C3 Metals on their latest news....

OPW.VN : 0.260 (-1.89%)
PSYG.CN : 0.0150 (unch)
CCCM.VN : 0.255 (-15.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.

See More

Key Turning Points

3rd Resistance Point 0.0217
2nd Resistance Point 0.0183
1st Resistance Point 0.0167
Last Price 0.0150
1st Support Level 0.0117
2nd Support Level 0.0083
3rd Support Level 0.0067

See More

52-Week High 0.1200
Fibonacci 61.8% 0.0780
Fibonacci 50% 0.0650
Fibonacci 38.2% 0.0520
Last Price 0.0150
52-Week Low 0.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar